Richard D. Carvajal

Northwell Health — United States

Medicine · Health Sciences

74h-index38.5kcitations703works1.12yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ocular Oncology and Treatments(174), Cancer Immunotherapy and Biomarkers(168), Immunotherapy and Immune Responses(148), CAR-T cell therapy research(100), Melanoma and MAPK Pathways(85)

Publications700 total

Computationally Assisted Patient Finding for Navigation to Optimize Pancreatic Cancer Care Access

The Oncologist·2026Open Access

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus

Cancers·2025Open Access

Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S4 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S7 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S1 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Supplementary Figures S1-S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table 3 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

2025Open Access

Table 2 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

2025Open Access

Supplementary Data 1 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

2025Open Access

Table 1 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

2025Open Access

Figure 2 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

2025Open Access

Figure 3 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

2025Open Access

Figure 1 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

2025Open Access

Supplementary Data from Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma

2025Open Access

page 1 of 35Next →

Frequent Co-authors

Gary K. Schwartz(12), Jeffrey A. Sosman(11), F. Stephen Hodi(10), Jedd D. Wolchok(10), Ryan J. Sullivan(9), Alexander N. Shoushtari(9), Mario Sznol(8), Katherine S. Panageas(8), Paul B. Chapman(8), Suzanne L. Topalian(7), Julie R. Brahmer(7), David F. McDermott(7), John D. Powderly(7), Michael A. Postow(7), Mark A. Dickson(7), David C. Smith(6), Michael B. Atkins(6), Drew M. Pardoll(6), Anthony M. Joshua(6), Josep M. Piulats(6)